Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs
- 12 October 2004
- journal article
- Published by Springer Science and Business Media LLC in The Pharmacogenomics Journal
- Vol. 4 (6), 354-358
- https://doi.org/10.1038/sj.tpj.6500284
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Comparison of Cytochrome P450 2C9 Genotyping Methods and Implications for the Clinical LaboratoryPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2004
- Comparative Assays for the HER-2/neu Oncogene Status in Breast CancerArchives Of Pathology & Laboratory Medicine, 2004
- Hepatitis C Genotyping by Denaturing High-Performance Liquid ChromatographyJournal of Clinical Microbiology, 2004
- Determination of HER-2 Status and Chromosome 17 Polysomy in Breast Carcinomas Comparing HercepTest and PathVysion FISH AssayAmerican Journal of Clinical Pathology, 2004
- A rapid and simple CYP2D6 genotyping assay—case study with the analgetic tramadolMetabolism, 2003
- Pharmacogenetics: potential for individualized drug therapy through geneticsTrends in Genetics, 2003
- CYP2D6 Poor Metabolizer Status Can Be Ruled Out by a Single Genotyping Assay for the −1584G Promoter PolymorphismClinical Chemistry, 2003
- Hepatitis C Virus Subtyping by a Core-Envelope 1-Based Reverse Transcriptase PCR Assay with Sequencing and Its Use in Determining Subtype Distribution among Danish PatientsJournal of Clinical Microbiology, 2003
- Hepatitis C Virus Genotyping: Interrogation of the 5′ Untranslated Region Cannot Accurately Distinguish Genotypes 1a and 1bJournal of Clinical Microbiology, 2002
- Pharmacogenomics: Translating Functional Genomics into Rational TherapeuticsScience, 1999